This HTML5 document contains 139 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-dehttp://de.dbpedia.org/resource/
dbpedia-shhttp://sh.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n18https://global.dbpedia.org/id/
dbpedia-trhttp://tr.dbpedia.org/resource/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
n7http://dbpedia.org/resource/List_of_drugs:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n14http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
dbpedia-srhttp://sr.dbpedia.org/resource/
freebasehttp://rdf.freebase.com/ns/
dbpedia-pthttp://pt.dbpedia.org/resource/
n15http://www.orpha.net/consor/cgi-bin/
n21http://commons.wikimedia.org/wiki/Special:FilePath/
dbpedia-fahttp://fa.dbpedia.org/resource/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
goldhttp://purl.org/linguistics/gold/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Givinostat
rdf:type
yago:WikicatHydroxamicAcids yago:Salt115010703 dbo:Drug yago:Carbamate114792281 yago:OrganicCompound114727670 yago:Chemical114806838 yago:Substance100019613 dbo:ChemicalSubstance n14:ChemicalObject yago:Matter100020827 yago:WikicatNaphthalenes yago:Hydrocarbon114911057 yago:Part113809207 owl:Thing yago:Relation100031921 yago:WikicatCarbamates yago:MethaneSeries114951377 yago:Abstraction100002137 yago:PhysicalEntity100001930 yago:WikicatAmines yago:Naphthalene114958564 yago:Compound114818238 yago:Amine114739004 yago:Acid114607521 yago:Material114580897 yago:AliphaticCompound114601294 wikidata:Q8386
rdfs:label
Givinostat Givinostat Givinostat
rdfs:comment
Givinostat ou gavinostat é um potêncial fármaco com propriedades anti-inflamatórias, antineoplásicas e antiangiogênese. Pertence a classe dos inibidores de HDAC (histone deacetylase). Givinostat ist ein in der klinischen Entwicklung befindlicher potenzieller Arzneistoff, der zur Behandlung der systemischen juvenilen idiopathischen Arthritis und der Polyzythämie eingesetzt werden soll. Arzneilich wird es als Hydrochlorid verwendet und befindet sich im Moment in Phase-2-Studien. Givinostat (INN) or gavinostat (originally ITF2357) is a histone deacetylase inhibitor with potential anti-inflammatory, anti-angiogenic, and antineoplastic activities. It is a hydroxamate used in the form of its hydrochloride. Givinostat is in numerous phase II clinical trials (including for relapsed leukemias and myelomas), and has been granted orphan drug designation in the European Union for the treatment of systemic juvenile idiopathic arthritis, polycythaemia vera. and Duchenne muscular dystrophy.
foaf:depiction
n21:Givinostat_structure.svg
dcterms:subject
dbc:Diethylamino_compounds dbc:Experimental_drugs dbc:Hydroxamic_acids dbc:Orphan_drugs dbc:Histone_deacetylase_inhibitors
dbo:wikiPageID
28807921
dbo:wikiPageRevisionID
1033026498
dbo:wikiPageWikiLink
dbr:Duchenne_muscular_dystrophy dbr:Myeloproliferative_disease dbr:QT_interval dbr:Pathophysiology dbc:Experimental_drugs dbr:Janus_kinase_2 dbr:Orphan_drug dbr:Polycythaemia_vera dbr:European_Union dbr:International_Nonproprietary_Name dbr:Hodgkin's_lymphoma dbr:Adverse_drug_reaction dbr:Anti-inflammatory dbr:Platelet dbr:Histone_deacetylase_inhibitor dbr:Hydrochloride dbr:Antineoplastic dbr:Interleukin_6 dbr:Salvage_therapy dbc:Hydroxamic_acids dbr:Juvenile_idiopathic_arthritis dbr:Diarrhea dbr:Erythrocyte dbr:Tumour_necrosis_factor dbc:Orphan_drugs dbr:Fatigue_(medical) dbc:Histone_deacetylase_inhibitors dbr:Leukopenia dbr:White_blood_cell dbr:Cytokine dbr:Histone_deacetylase dbr:Interleukin_1 dbr:Hydroxamate dbc:Diethylamino_compounds dbr:Thrombocytopenia dbr:Anti-angiogenic
dbo:wikiPageExternalLink
n15:OC_Exp.php%3Flng=EN&Expert=85414%7Cat=Orphan
owl:sameAs
freebase:m.0ddbwzg dbpedia-sr:Givinostat n18:3wyap wikidata:Q426257 dbpedia-fa:جیوینوستات dbpedia-de:Givinostat dbpedia-sh:Givinostat yago-res:Givinostat dbpedia-tr:Givinostat dbpedia-pt:Givinostat
dbp:wikiPageUsesTemplate
dbt:Refbegin dbt:Drugbox dbt:HDAC_inhibitors dbt:Cite_web dbt:Cite_journal dbt:Drugbankcite dbt:Chemspidercite dbt:Cascite dbt:Fdacite dbt:Refend dbt:Stdinchicite dbt:Reflist
dbo:thumbnail
n21:Givinostat_structure.svg?width=300
dbp:atcPrefix
none
dbp:c
24
dbp:casNumber
497833
dbp:chemspiderid
7980752
dbp:h
27
dbp:iupacName
{6-[methyl]naphthalen-2-yl}methyl [4-phenyl]carbamate
dbp:legalUs
IND
dbp:n
3
dbp:o
4
dbp:pregnancyCategory
dbp:pubchem
9804992
dbp:routesOfAdministration
Oral
dbp:smiles
O=CNc3cccCNO
dbp:stdinchi
1
dbp:stdinchikey
YALNUENQHAQXEA-UHFFFAOYSA-N
dbp:unii
5
dbp:verifiedfields
changed
dbp:verifiedrevid
451563965
dbp:watchedfields
changed
dbo:abstract
Givinostat ist ein in der klinischen Entwicklung befindlicher potenzieller Arzneistoff, der zur Behandlung der systemischen juvenilen idiopathischen Arthritis und der Polyzythämie eingesetzt werden soll. Arzneilich wird es als Hydrochlorid verwendet und befindet sich im Moment in Phase-2-Studien. Givinostat (INN) or gavinostat (originally ITF2357) is a histone deacetylase inhibitor with potential anti-inflammatory, anti-angiogenic, and antineoplastic activities. It is a hydroxamate used in the form of its hydrochloride. Givinostat is in numerous phase II clinical trials (including for relapsed leukemias and myelomas), and has been granted orphan drug designation in the European Union for the treatment of systemic juvenile idiopathic arthritis, polycythaemia vera. and Duchenne muscular dystrophy. A preclinical study produced early results suggesting the molecule might help with diastolic dysfunction. ITF2357 was discovered at Italfarmaco of Milan, Italy. It was patented in 1997 and first described in the scientific literature in 2005. Givinostat ou gavinostat é um potêncial fármaco com propriedades anti-inflamatórias, antineoplásicas e antiangiogênese. Pertence a classe dos inibidores de HDAC (histone deacetylase).
dbp:iupharLigand
7490
dbp:legalEuComment
Orphan status for sJIA
gold:hypernym
dbr:Inhibitor
prov:wasDerivedFrom
wikipedia-en:Givinostat?oldid=1033026498&ns=0
dbo:wikiPageLength
8655
dbo:casNumber
497833-27-9
dbo:fdaUniiCode
5P60F84FBH
dbo:pubchem
9804992
foaf:isPrimaryTopicOf
wikipedia-en:Givinostat
Subject Item
dbr:Histone_deacetylase_inhibitor
dbo:wikiPageWikiLink
dbr:Givinostat
Subject Item
n7:_G
dbo:wikiPageWikiLink
dbr:Givinostat
Subject Item
dbr:Gavinostat
dbo:wikiPageWikiLink
dbr:Givinostat
dbo:wikiPageRedirects
dbr:Givinostat
Subject Item
dbr:ITF2357
dbo:wikiPageWikiLink
dbr:Givinostat
dbo:wikiPageRedirects
dbr:Givinostat
Subject Item
wikipedia-en:Givinostat
foaf:primaryTopic
dbr:Givinostat